Report Highlights
The global market for sports medicine market should grow from $7.7 billion in 2021 to $10.3 billion by 2026, at compound annual growth rate (CAGR) of 6.0% for the period of 2021-2026.
Report Includes
- 37 tables
- An updated review of the global markets for sports medicine products and related technologies
- Analyses of the global market trends, with data from 2019-2020, estimates for 2021, and projections of compound annual growth rates (CAGRs) through 2026
- Evaluation and forecast the overall sports medicine market size in dollar value terms, and corresponding market share analysis by product type, application, and geographic region
- Discussion of emerging trends and advancements in the product pipeline of sports medicine market, as well as new approaches to deal with injuries and conditions related to sports and other intense physical activities
- Latest information on major market dynamics (DROs), recent developments, technology updates, industry structure, regulatory approvals, and other significant factors affecting the global sports medicine market growth
- Identification of the major stakeholders and analysis of the competitive landscape based on recent developments and segmental revenues
- Impact analysis of COVID-19 pandemic on the market for sports medicine products
- Profile descriptions of the leading industry players including Anika Therapeutics Inc., Bioventus LLC, DePuy Synthes, Emcyte Corp., Medtronic PLC, Orthofix, Smith & Nephew PLC, and Stryker Corp.,
Report Scope
This report aims to provide a comprehensive study of the global market for sports medicine products. It provides a detailed description of the different types of sports medicine products (body reconstruction and repair, body support and recovery, and accessories), and their current and historical market revenues. Each product type market is further segmented based on technology. Body reconstruction and repair products are categorized in capital equipment solutions, implants, instruments and consumables, orthobiologics and prosthetic devices. Body support and recovery products are divided into braces and supports, compression clothing, and physiotherapy equipment.
The market for sports medicine products is also segmented by application, namely knee injuries; shoulder injuries; ankle, thigh and foot injuries; elbow, hand and wrist injuries; hip injuries; back and spine injuries; and other injuries. The market revenue for each geographic segment (North America, Europe, Asia-Pacific, and the Rest of the World (RoW) is reported and forecast. For each region, the market in principal countries is also provided.
For an in-depth understanding of the market, profiles of market participants, competitive landscape, key competitors, and their respective market share are also part of this report. This report also discusses driving and restraining factors of the global sports medicine products market along with new developments and approvals for sports medicine products.
Analyst Credentials
BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.
- Bioprocess Optimization and Digital Bio-manufacturing: Global Markets (BIO170B)
- Metal-organic Frameworks: Global Markets (AVM200B)
- Laboratory Animal Models, 3D Cultures, and Organoids: Global Markets (PHM204C)
- Global DNA Sequencing: Research, Applied and Clinical Markets (BIO045J)
- Surgical Equipment: Technologies and Global Markets (HLC154C)
Report Highlights
The global sports medicine market totaled $29.8 billion in 2013 and $31.1 billion in 2014. The market is expected to reach $43.3 billion by 2019, a compound annual growth rate (CAGR) of 6.8%.
Report Includes
- An overview of the global markets and technologies for sports medicine.
- Analyses of global market trends, with data from 2012, 2013 and 2014, and projections of compound annual growth rates (CAGRs) through 2019.
- Examination of recent trends and advancements in the product pipeline of the sports medicine market as well as new approaches to deal with sports injuries.
- Coverage of body reconstruction products like orthopedic implants, fracture repair and arthroscopy devices, and prosthetics; body support and recovery products such as braces and support, hot and cold therapies, pain relievers and anti-inflammatory and compression systems; accessories like bandages, tapes, wraps, and monitoring devices.
- Examination of the market's dynamics, specifically growth drivers, restraints, and opportunities.
- Breakdowns of the market by application into shoulder, knee, hip, ankle and foot, and others.
- Relevant patent analysis.
- Comprehensive profiles of major players in the sports medicine industry.
Related Reports
Global Orthodontic and Orthopedic Market
The global market for orthodontic devices is expected to grow from $18.9 billion in 2023 and projected to reach $29.3 billion by the end of 2028, at a compound annual growth rate (CAGR) of 9.2% during the forecast period of 2023 to 2028.Report Includes
Markets for Advanced Wound Management Technologies
The global advanced wound management products market reached $10.7 billion in 2022 and should reach $15.3 billion by 2028, with a compound annual growth rate (CAGR) of 6.2% during the forecast period of 2023-2028.
Advanced Orthopedic Technologies, Implants and Regenerative Products
The global market for advanced orthopedic technologies, implants, and regenerative products is estimated to increase from $66.4 billion in 2023 to reach $84.8 billion by 2028, at a compound annual growth rate (CAGR) of 4.1% from 2023 through 2028.
Regenerative Medicines: Bone and Joint Applications
The global market for regenerative medicine in bone and joint applications reached $9.6 billion in 2022. The market is estimated to increase from $10.7 billion in 2023 to $18.9 billion by 2028, at a compound annual growth rate (CAGR) of 12.1% from 2023 through 2028.
Recent Reports
Surgical Equipment: Technologies and Global Markets
The global market for surgical equipment and technologies was valued at $37.6 billion in 2023. This market is expected to grow from $40.0 billion in 2024 to $56.6 billion by 2029, at a compound annual growth rate (CAGR) of 7.2% from 2024 to 2029.
Conventional and Alternative Pain Treatment Markets
The global market for conventional and alternative pain treatment is expected to grow from $96.2 billion in 2024 and is projected to reach $144.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 8.4% during the forecast period of 2024 to 2029.
CRISPR Technology: Global Markets
The global market for CRISPR technology was valued at $3.4 billion in 2023. This market is expected to grow from $3.8 billion in 2024 to $7.5 billion by the end of 2029, at a compound annual growth rate (CAGR) of 14.4% from 2024 to 2029.
Chronic Disease Management: Therapeutics, Device Technologies and Global Markets
The global market for chronic disease management therapeutics and device technologies was valued at $675.0 billion in 2023. It is projected to grow from $726.3 billion in 2024 to $1.1 trillion by 2029, at a compound annual growth rate (CAGR) of 8.1% from 2024 through 2029.
Medical Devices: Technologies and Global Markets
The global market for medical devices reached $739.6 billion in 2023. It is expected to grow from $810.4 billion in 2024 to $1.3 trillion by the end of 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.
Top Trending Reports
Single-use Technologies for Biopharmaceuticals: Global Markets
The global market for single-use technologies for biopharmaceuticals is expected to grow from $6.5 billion in 2024 and is projected to reach $11.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 11.6% during the forecast period of 2024 to 2029.
Cell and Gene Therapy Tools, and Reagents: Global Markets
The global market for Cell and Gene Therapy (CGT) Tools and Reagents is estimated to increase from $10.0 billion in 2024 to reach $16.7 billion by 2029, at a compound annual growth rate (CAGR) of 10.8% from 2024 through 2029.
Medical Devices Industry: Competitive Landscape
The global market for medical devices is estimated to increase from 810.4 billion in 2024 to reach $1.3 trillion by 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.
Global Market Opportunities and Competitive Landscape for CDMO
The global CDMO market was valued at $128.0 billion in 2023. This market is expected to grow from $136.6 billion in 2024 to $191.6 billion by the end of 2029, at a compound annual growth rate (CAGR) of 7.0% from 2024 to 2029.
Chronic Disease Management: Therapeutics, Device Technologies and Global Markets
The global market for chronic disease management therapeutics and device technologies was valued at $675.0 billion in 2023. It is projected to grow from $726.3 billion in 2024 to $1.1 trillion by 2029, at a compound annual growth rate (CAGR) of 8.1% from 2024 through 2029.
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More